Economic Graham
costs of obesity13
A Colditz Approximately
in
1980.
Obesity
insulin-dependent cardiovascular and colon
diabetes
approach
mellitus
costs
in
conditions.
to cost
1986
costs
discounted at 4%. Overall, $1 1.3 billion for NIDDM, ease,
$2.4
ofcosts
due
7.8%.
of the
costs
against
KEY
of 3 1.0%
38.5%
among
for
the
these
ceo-
medical
mortality
costs
of illness
disorders
of treatment
the
WORDS
costs,
costs
to musculoskeletal
raise
severe
health
1986. this
obesity
status
and
economic
direct
costs,
into
Moreover,
overweight
and obesity
risk factor for many disease (CVD) and
exacerbate
many
of
making
types:
prey-
were obese (overweight) adults were severely
Thus,
a major
portion
risk ofdisability,
of being
of
is more
(7) and is more common Americans than among
obese
costs ofillness
to a maximum
obesity
of the
disease,
adult
and pre-
overweight.
play an important
(9). Cost-of-illness
prevalence-based
and
studies
role in health can
be divided
incidence-based
analyses.
stage
ofdisease.
Prevalence-based
estimates
are particularly
well suited to estimating the magnitude of disease costs on an annual basis as well as assessing the economic burden attributable to acute or transient conditions. This approach does not, however, quantify the long-term consequences ofcurrent behaviors and chronic underlying conditions, such as smoking and being obese. For these purposes an incidence-based approach would
indirect
chronic diabetes.
chronic
by virtue
27.8
to a max-
prevalence-based approach identifies the costs incurred during a given year by persons with a particular illness, regardless
Introduction (overweight) is a major such as cardiovascular
Overall,
of these
overweight).
decision two
million
as BMI
increases
The
be
prevalence
Obesity diseases,
65-74.
is at increased
death
ofthe costs,
12.4
The economic
l992;55:503S-7S.
Obesity,
and
(severely
policy
quality
y of age and
whites
1980,
mature
was
must
45-54
aged
criteria,
US population
estimate
for men
women
(see Fig I) (8). 34 million adults
obese
Addition
for women,
nonHispanic in
defined
kg/rn2
than among men blacks and Mexican
By these
were dis-
(overweight),
27.3
alent among women among nonHispanic
were
of obesity
in
could
for
improved
Am J Clin Nuir
life.
irnurn
and
economic
and
hypertension,
the costs attributable to obesity $22.2 billion for cardiovascular
of the
or 5.5%
The
weighed
to obesity
ofobesity
for men
cholecystectorny, Using a prevaestimated
to morbidity
The prevalence kg/rn2
gall
estimate
billion,
to
for
and
$39.3
we
were of non-
bladder disease, $1.5 billion for hy$ I .9 billion for breast and colon cancer. Thus
billion
pertension, a conservative
risk
(NIDDM),
of illness,
due
adults
increased
disease and breast cancer.
attributable
Indirect
US
million with
disease, gallbladder and postmenopausal
lence-based nomic
34
is associated
be more
appropriate.
To complete
such
an analysis
reliable estimates ofthe incidence ofdisease sity at each age and for each gender. Although
dis-
would
require
attributable to obesuch an approach
eases (eg, hypertension, dyslipoproteinernia, osteoarthritis, and other musculoskeletal problems) (1). The prevalence of obesity in the United States is higher than that in Canada and the United
would provide an estimate of the lifetime costs of obesity, focused the current analysis on the annual economic impact obesity, using estimates ofthe prevalence and the proportion
Kingdom women
disease
index
(2). Data from representative samples ofUS men and 18-34 y of age show little variation in mean body mass
(BMI)
The
over a 20-y period
US population
from
is unlikely
1960 through
1980 (3, 4). in the near term. In
to get leaner
addition, women,
black women are on average more obese than a difference that is not explained by differences
ucation
or income
the
cost
of these
perspective
(3). The
health
conditions
of health
are
consequences therefore
of obesity important
the
value
sicians’
and
to obesity.
costs represent the monetary premature death as foregone in terms of direct and indirect
measured
white in ed-
from
attributable
Economic illness and
of resources services,
we of of
nursing
(personal home
health care,
burden on society of alternatives and are costs. Direct costs are care,
other
hospital professional
care,
phy-
services,
and drugs) that could be allocated to other uses in the absence of disease. Indirect costs are the value of lost output because of cessation or reduction of productivity caused by morbidity and
the
policy.
In 1980, ±
65.4
the mean weight of US males 18-74 y old was 78.1 1 3.5 kg (1 ± SD), and for US women of the same age it was ±
14.7
kg (5).
The
National
Center
defines overweight as BMI 85th percentile aged 20-29 y. Severe overweight is defined percentile (6). The 20-30-y-old population ence because these young adults in body weight with aging are
for
Health
Statistics
I From the Channing Laboratory, Brigham and Women’s Hospital and Harvard Medical School; and the Department of Epidemiology, Harvard School of Public Health, Boston. 2 Supported by research grant DK 36798 from the National Institutes of Health. 3 Address reprint requests to GA Colditz, Channing Laboratory, 180 Longwood Avenue, Boston, MA 02 1 15-5899.
ofmen and women as a BMI > 95th is used as the refer-
are relatively lean, and increases almost entirely due to fat accu-
mulation. Am J C/in Nuir
1992:55:5035-75.
Printed
in USA.
© 1992 American
Society
for Clinical
Nutrition
503S
Downloaded from https://academic.oup.com/ajcn/article-abstract/55/2/503S/4715327 by guest on 19 November 2018
ABSTRACT obese
COLDITZ
504S Prevalence
of
Overweight
Mencon
_
A,ner,con
Puerto
Picsnt
Rcon
bined
Non-Hieponic
Non-Hiapo&c
white
block
Cubort
11
increases
and
per
capita
care
expenditures
ductivity
from
1980
through
health
care
expenditures.
The
costs)
majority
of
amounted
incident
among men and women of cases were diagnosed > 28.3 kg/rn2 (18), and
Mole
FIG
cases
of
persons
Nutrition
Examination
and Nutrition ence 8.)
to
ofthe
percentage
amounts
Economic
costs
percentage of overweight Hispanic and nony of age. Data from the Hispanic Health and
20-74
Survey,
1982-84,
Examination
Survey,
and
the Second
1976-80.
National
(Reproduced
Health
from
refer-
The incidence tinuously with cystectomies
Morbidity
costs
able to work because value for persons too tasks. lost
Mortality
are wages
lost
of illness and sick to perform
costs
are
the
by people
diabetes
mellitus
(1 1), gall bladder
disease
present
value
( 13) (among
both
postmenopausal costs
men
for that
portion
(14,
and
chronic
with data relating analyses is estimation
tion of disease among studies use cutoff points
Center lars.
for Health Indirect
costs
due
breast
cancer
study
rate of 4%.
Economic
costs
used
to estimate
the
1986
are
in detail
those
due
related diabetic diabetic
of gall
to routine
to morbidity ketoacidosis, neuropathy;
that
CVD
overall,
57%
(0.6 1 X 0.94
are attributable
and
The
to obesity.
This
disease
Health
Study
population
BMI 29 kg/rn2 199 1 ).An estimated
were
(M Stampfer, 90% of these
perpercases
to obesity, and hence, 30% of the estimated associated with gall bladder disease are attribThis
is attrib-
figure
risk
of CVD
of CVD
adjustment
amounts
to $2.4
for
rises
billion.
with
(9) by 73%
BMI.
hypertension) This
trend
is most
evident
( I I) (see Fig 3). The costs by first inflating the direct costs reported
were estimated
1980
(excluding
for cigarette
measured by the Index (CPI) and
One lirnipropor-
are based
costs
ofCVD
the
in 1986 dol-
mortality
bladder
Nurses’ whose
to obesity.
after
ofsevere obewe focused in general and
All costs are expressed
costs care and
increases
levels
with
(see FIG 2) (10). of NIDDM elsewhere
smoking
to reflect
the
increase
medical component the increase in the
in medical
expenses
of the Consumer US population.
Price Indirect
costs were increased by a factor of 4 1% for men and 59% for women to reflect the increase in wages from I 980 to I 986. Because direct costs of hypertension account for 1 3.6% of total
CVD ofcosts could
personal
health
care
expenditure,
($7.6 billion) from be analyzed separately.
CVD
were attributed
from
the
1986
to NIDDM,
estimates.
we subtracted
the direct Because The
this portion
costs ofCVD so that this a portion of the costs of
these costs were also subtracted indirect
costs
of mortality
from
on
for
United
These
uncomplicated from
diabetic coma, and those that
by inflating
rising BMI; there is The procedures we
in the (16).
mortality
orders. To estimate costs we began 1980 US health care expenditure to 1986
y of age with BMI 94% of NIDDM
of clinically symptomatic gallstones rises conincreasing BMI. Approximately 33% of chole-
were attributable $8 billion costs utable
Many of the epidemiologic those defined by the National
an excess prevalence ofother disease with NIDDM, including circulatory,
mates
30-64 women,
of NIDDM
The incidence of NIDDM no evidence of a threshold set out
diagnosed
to $ 1 1.3 billion.
in the
Economic
we estimate
conditions
to morbidity
a discount
un-
cancer (among
colon
to severe obesity. of the attributable
the obese. other than
Statistics.
and
(12),
utable to obesity. Because ofthe relatively low overall prevalence sity (ie, only 36.5% of the total obese population), this economic analysis on the costs of obesity then concluded tation in these
are
In Rochester, MN, 59% and women with BMI Health Study, 61% of
earnings
hypertension
15). In this
of these
are
of non-insulin-de-
cholecystectomy
and women),
women)
of future
risk
(NIDDM)(l0), and
who
disability and an imputed their usual housekeeping
by people who die prematurely. Obesity is associated with increased
pendent
Thus
ofNIDDM
formed on women sonal communication, mortality.
obesity.
costs
pro-
billion.
NIDDM
who are obese. among men in the Nurses’
of health
Female
1 . Age-adjusted
Hispanic
attributable 0.57)
costs
and foregone
with
States
costs
in
include
NIDDM;
those
complications
such
diabetic retinopathy, arise as a consequence conditions among visual, renal, and
as and of
persons skin dis-
published estimates of the (1 7). We adjusted these esti-
them
in proportion
to the com-
22
22-22.9
23-23.9
24-24.9
25-26.9
-#{247}-45-49
..
27-28.9
50-54
FIG 2. Incidence of NIDDM according US women 30-64 y ofage. (Adapted from
29-30.9
--
31-32.9
33.34.9
35.
55-62
to BMI
reference
in a population
10.
of
Downloaded from https://academic.oup.com/ajcn/article-abstract/55/2/503S/4715327 by guest on 19 November 2018
=
US population
to $8.2
cases were diagnosed among women 29 kg/rn2 (10). Among these obese was
in the Direct
for $ 1 1 .6 billion,
accounted
(indirect
1986
ECONOMIC
COSTS
OF
505S
OBESITY
BMI
FIG 3. Relative risk of nonfatal myocardial infarction and fatal coronary heart disease (combined). according to categories of BMI in a cohort ofUS women who were 30-55 y ofage in 1976 and were followed for 8 y. (Adapted from reference 1 1.)
CVD
40% of the costs of obesity are attributable for severe
general
of surgery,
profiles
Yates
obesity.
Further,
the costs
of treatment
the indirect costs ofpremature death as a complication and the reduced costs of care due to improved risk
ofsurgery,
factor
to severe
obesity must be added to those outlined above for the obese population. These costs include the direct costs
and
better
reported
(26)
control
of NIDDM.
the average
charges
forjejunoileal
bypass
and gastric
bypass, which, inflated to 1986, are $10 8 13 for opand follow-up. This estimate was based on a survey rerate of only 17.6%, which limited its reliability. To esthe costs of surgery, we must add the indirect costs as-
eration sponse tirnate sociated
with
rate that
premature
premature
death
occurs
If the
profiles
widely
(30),
and
reported
improved
above,
for severe obesity and will be minor. Other improved
glucose
tolerance
the additional indirect benefits
psychological
are seen
suggest
Adventist among
Thus,
may and
to persist
relation
between
causes
ofdeath
other
been
omitted
from
have the
proportion
Phillips
may
of disease
and
and
men
100-109,
risk women
of colon (25)
observed
comparing
those
although
this
study suggests a major proportion may be attributable to obesity.
may
several (uterus
among
men
for women
may
small.
of 1 .45
from
Prospective with
an attrib-
follow-up
support
no association
Snowden of 3.3,
to risk
be too
(23). Data
for the costs
and
related
our estimate
a relative men
men
our estimate
tribution
among
cancer
is based
of25
women
may
as(25).
be conser-
an adjusted with
493
a stronger
relative
relative
on small
of colon cancer However, we note
weight numbers. among that we
female reproductive cancers and ovary), hence the female
that con-
be reasonable.
We have not included an estimate of the costs of obesity attributable to musculoskeletal disorders. If we assume that the relation of all muskuloskeletal disorders to obesity is similar to that observed for osteoarthritis (36), then 50% of the costs of these disorders may be attributable to obesity. This amounts to some
$17
billion.
Inclusion
of this
contribution
brings
the total
of obesity to 7.8% of the US total costs of illness. We conclude that obesity represents a major avoidable contribution to the costs ofillness in the United States. One approach costs
to containing States could ing weight
the rapidly rising be the implementation gain
in middle
I thank Christine assistance
in preparing
L Pappas,
and Anne
health care costs in the United ofprograms aimed at avoidlater
B
life.
Wolf, and JoAnn
Manson
for their
this material.
among
for obesity
direct
costs
due
and
patients
after
associated
weight
of $39.3 3.
to surgery mortality include the
quality
1.
2.
the associated
costs due to premature not considered here
status
obese
and
References
oflife
4.
that
loss (32). 5.
Conclusions We provide quences
appears
lifetime
decreased need for medication (31). In contrast to the total cost estimates billion
effect inverse
strongly
of ‘-30%
have not considered are related to obesity
at a
in the literature but that may be -0. 1% earnings for a 34-y-old man are estimated at $785 488 and those for a 34-y-old woman at $592 426, even a mortality rate as low as 0. 1% (28) adds substantially to the cost oftreatment. Against this cost we must balance the reduction in cost due to improved cardiac function (29), improved lipid (27).
varies
mortality;
cancer
is more
Hawaii
among
This men
Costs
(35).
prevalence
obesity
> 125 to those
in 1986.
and
proportion
vative. risk
represents
fracture
This strong
than among women. Accordingly, be too large and that for men
Thus
attributable
the
among the obese population attributable to obesity were inferred from prospective studies. This may lead to some imprecision in our estimates. In addition, with respect to colon cancer, it is
sociation
to obesity
ofhip
estimates. of the
Seventh-day
Total
(34).
despite
diabetes,
current Estimates
utable
billion.
weight
groups,
and
than the
relative
age
a conservative
ofobesity.
We have
on musculoskeletal lower incidence
disorders than colon
cancer.
mortality
Further,
estimate of the economic consenot considered the impact of obesity (33) or on several cancers that have cancer and postmenopausal breast data
indicate
that
total
mortality
in-
6. 7. 8.
US Dept of Health and Human Services. The Surgeon General’s report on nutrition and health. Washington, DC: US Government Printing Office. [DHHS publication (PHS) 88-50210.] Millar WJ, Stephens T. The prevalence of overweight and obesity in Britain, Canada. and the United States. Am J Public Health 1987;77:38-4 1. Flegal KM, Harlan WR, Landis JR. Secular trends in body mass index and skinfold thickness with socioeconomic factors in young adult women. Am J Clin Nutr l988;48:535-43. Regal KM, Harlan WR, Landis JR. Secular trends in body mass index and skinfold thickness with socioeconomic factors in young adult men. Am J Clin Nutr 1988;48:544-5l. National Center for Health Statistics, Najjar MF, Rowland M. Anthropometric reference data and prevalence of overweight, United States, 1976-1980. Vital Health Stat [1 1] 1987;238:l-73. Van Itallie TB. Health implications ofoverweight and obesity in the United States. Ann Intern Med 1985;103:983-8. National Center for Health Statistics. Health, United States, 1989. Hyattsville, MD: Public Health Service, 1990. Life Sciences Research Office, Federation of American Societies for Experimental Biology. Nutrition monitoring in the United States-
Downloaded from https://academic.oup.com/ajcn/article-abstract/55/2/503S/4715327 by guest on 19 November 2018
1.1% ofcancer
As for
to obesity,
cancers.
1 1% of all diagnosed
additional
obese.
attributable
creases
ECONOMIC an update Government 1255.]
report on nutrition Printing Office,
monitoring. 1989. [DHHS
9. Rice DP, Hodgson TA, Kopstein a replication and update. Health 10. Colditz GA, Willett for clinical diabetes
Washington, publication
AN. The economic Care
Financ
Rev
COSTS
DC: (PHS)
costs of
US 89-
illness:
OF 22.
23.
l985;7:6l-80.
WC, Stampfer MJ, et al. Weight as a risk factor in women. Am J Epidemiol l990;l32:50l-l3.
1 1. Manson JE, Colditz GA, Stampfer Mi, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J
24.
25.
Med l990;322:882-9. 26.
13. Lew EA, Garfinkel L. Variations 750,000 men and women. J Gin
among
27.
in relation to breast cancer morbidity study of 570,000 women in Norway.
28.
14. Tretli S. Height and weight and mortality. A prospective Int J Cancer l989;44:23-30.
in mortality by weight Epidemiol 1979;32:563-76.
15. London SJ, Colditz GA, Stampfer MJ, WilIest WC, Rosner B, Speizer FE. A prospective study of relative weight, height, and the risk of breast cancer. JAMA l989;262:2853-8. 16. Huse DM, OsterG, Killen AR, Lacey MJ, Colditz GA. The economic costs of non-insulin-dependent diabetes mellitus. JAMA 1989;262: 2708-13. 17. Hodgson TA, Kopstein AN. Health care expenditures for major diseases in 1980. Health Care Financ Rev l984;5:l-12. 18. Melton LI III, Palumbo PJ, Dwyer MS, et al. Impact diagnostic criteria on the apparent history ofdiabetes J Epidemiol 1983;l 17:559-65. 19. Witteman JCM, Willets WC, Stampfer of nutritional factors and hypertension lation l989;80: 1320-7. 20.
ofchanges mellitus.
Mi, et al. A prospective among US women.
in Am study
30. 31.
32.
33.
Circu-
Rice DP, Hodgson TA, Capell F. The economic burden of cancer, 1985: United States and California. In: Sheffier RM, Andrews NC, eds. Cancer care and costs 1989. Ann Arbor, MI: Health Administration Press, 1989:39-59.
21. Coates Ri, Clark WS, Eley JW, et al. Race, nutritional status, survival from breast cancer. J Natl Cancer Inst 1990;82:1684-92.
29.
and
34. 35. 36.
507S
Ries LAG, Hankey BF, Edwards BK. Cancer statistics review 19731987. Bethesda, MD: National Cancer Institute, [DHHS publication (NIH) 90-2789.] Nomura A, Heilbrun LK, Stemmerman DN. Body mass index as a predictor of cancer in men. J Natl Cancer Inst l985;74:3l9-23. Stemmerman GN, Nomura AM, Heilbrun LK, Pollack ES, Kagan A. Serum cholesterol and colon cancer incidence in Hawaiian Japanese men. J Natl Cancer Inst l98l;67:l 179-82. Phillips RI., Snowden DA. Dietary relationships with fatal colorectal cancer among Seventh-Day Adventists. J NatI Cancer Inst l985;74: 307- 17. Yates BT. Survey comparison ofsuccess, morbidity, mortality, fees and psychological benefits and costs of 3,146 patients receiving jejunoileal or gastric bypass. Am J Gin Nutr l980;33:5 18-22. Drenick El, Fisler JS. Sudden cardiac arrest in morbidly obese surgical patients unexplained after autopsy. Am J Surg l988;l55: 720-6. Mason EE, Renquist KE, Jiang D. Perioperative risks and safety of surgery for severe obesity. Am J Clin Nutr l992;55(suppl):573S6S. Benotti PN, Bistrian B, Benotti JR, Blackburn G, Forse RA. Heart disease and hypertension in severe obesity: the benefits of weight reduction. Am J Clin Nutr l992;55(suppl):586S-90S. Gleysteen ii. Results ofsurgery: long-term effects on hyperlipidemia. Am J Clin Nutr l992;55(suppl):591S-3S. Pories Wi, MacDonald KG Jr. Morgan EJ, et al. Surgical treatment ofobesity and its effect on diabetes: lO-y follow-up. Am J Clin Nutr l992;55(suppl)582S-5S. KraI JG, Sj#{246}str#{246}m L, Sullivan MBE. Assessment of quality of life before and after surgery for severe obesity. Am J Clin Nutr 1992;55(suppl)6 1 15-45. Davis MA, Ettinger WH, Neuhaus JM, Hauck WW. Sex differences in osteoarthritis of the knee. The role of obesity. Am J Epidemiol l988;l27: 1019-30. Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity. A reassessment. JAMA l987;257:353-8. Kelsey JL, Hoffman S. Risk factors for hip fracture. N Engl J Med 1987;3 16:404-6. Davis MA, Ettinger WH, Neuhaus JM, Hauck WW. Sex differences in osteoarthritis of the knee. The role of obesity. Am J Epidemiol 1988;l27: 1019-30.
Downloaded from https://academic.oup.com/ajcn/article-abstract/55/2/503S/4715327 by guest on 19 November 2018
12. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Weight, diet, and the risk ofsymptomatic gallstones in middle-aged women. N Engl J Med l989;32l:563-9.
OBESITY